Joel Greenberg
Neurology · Savannah, GANPI 1518909639
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 562 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,934 and has fallen 96.1% since, to $114 in 2022.
Across 562 payments — averaging $12.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$1K
- AbbVie$662
- Biogen$512
- Sunovion Pharmaceuticals Inc.$492
- Novartis$431
- Teva Pharmaceuticals USA, Inc.$430
- plus $3K from 38 others
What the payments were for
- Speaking & faculty fees$1342%
- Food & beverage$6,75298%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,886 in reported general payments places this provider in the 70th percentile of 506 neurology providers in Georgia.
Other neurology in Savannah
- Victor RosenfeldSavannah$413K
- Robert MacgregorSavannah$49K
- Brandi FleenorSavannah$47K
- Stephen DonahueSavannah$25K
- Mitzi WilliamsSmyrna$1.4M
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- John MorganAugusta$715K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.